Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2011
10/19/2011EP2375905A1 Pharmaceutical composition containing an n-phenylpyrazole derivative, and use thereof for preparing a topical veterinary drug for flea control
10/19/2011EP2375904A1 Biaryl carboxamides
10/19/2011EP2375903A1 A method of treating insomnia
10/19/2011EP2375900A1 Methods for treating multiple sclerosis using tetracyclic pyrazinoindoles
10/19/2011EP2375899A1 Piperidine-containing compounds and use thereof
10/19/2011EP2375897A1 Methods and compositions containing mtor inhibitors for enhancing immune responses
10/19/2011EP2375895A1 Method for treating alzheimer's disease and related conditions
10/19/2011EP2363142A9 Elastase for opening obstructed biological conduits
10/19/2011EP2276759B1 3-indazolyl-4-pyridylisothiazoles
10/19/2011EP2225245B1 N-phenyl-imidazo(1,2-a)pyridine-2-carboxamide compounds, preparation thereof and therapeutic application thereof
10/19/2011EP2221377B1 Oligonucleotide compositions with enhanced efficiency
10/19/2011EP2214628B1 Orodispersible composition comprising polyunsaturated fatty acids without bad odour or taste
10/19/2011EP2187767B1 Increased creatine retention with soluble fibres
10/19/2011EP2170857B1 3',4',5-trimethoxy flavone derivatives as stimulant of mucus secretion, method of the same, and pharmaceutical composition comprising the same
10/19/2011EP2162125B1 Composition for rectal administration combined with an oral alpha-lipoic acid composition for the treatment of inflammatory bowel disease
10/19/2011EP2101569B1 Crystalline solid rasagiline base
10/19/2011EP2018380B1 Cns active fused bicycloheterocycle substituted azabicyclic alkane derivatives
10/19/2011EP2004607B1 (4-(4-[6-(trifluoromethyl-pyridin-3-ylamino)-N-containing-heteroaryl]-phenyl)-cyclohexyl)-acetic acid derivatives and pharmaceutical uses thereof
10/19/2011EP1968601B1 Salts of potassium atp channel openers and uses thereof
10/19/2011EP1966209B1 [ 1h- indol- 5 -yl) -heteroaryloxy] - (1-aza-bicyclo [3.3.1] nonanes as cholinergic ligands of the n-achr for the treatment of psychotic and neurodegenerative disorders
10/19/2011EP1965798B1 Useful monobactam antibiotics
10/19/2011EP1957451B1 Soft anticholinergic zwitterions
10/19/2011EP1948596B1 Soft anticholinergic esters
10/19/2011EP1937250B1 Ligustilide derivatives for the treatment of inflammatory disorders
10/19/2011EP1923387B1 Acylguanidine derivative or salt thereof
10/19/2011EP1917012B1 Cell migration modulating compounds
10/19/2011EP1910379B1 Caspase inhibitor prodrugs
10/19/2011EP1899302B1 Phenoxy acetic acids as ppar delta activators
10/19/2011EP1896473B1 1-[[2-amino-3-(substituted alkyl)-3h-benzimidazolyl]methyl]-3-subtituted-1,3-dihydro-benzoimidazol-2-ones as inhibitors of respiratory syncytial virus replication
10/19/2011EP1891075B1 Tricyclic spiro derivatives as crth2 modulators
10/19/2011EP1871380B1 Combined use of prostaglandin compound and proton pump inhibitor for the treatment of gastrointestinal disorders
10/19/2011EP1851210B1 Nitro-substituted phenyl-piperazine compounds, their preparation and use in medicaments
10/19/2011EP1809379B1 Process for preparing (3-(2(r)-((1r)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3(s)-(4-fluorophenyl)morpholin-4-yl)methyl)-5-oxo-4,5-dihydro-(1,2,4)-triazol-1-yl) phosphonic acid
10/19/2011EP1782831B1 External preparation
10/19/2011EP1782816B1 Water-based medicinal composition containing azithromycin and method of preparing the same
10/19/2011EP1773310B1 Alpha, beta-unsaturated sulfones, sulfoxides, sulfonimides, sulfinimides, acylsulfonamides and acylsulfinamides and therapeutic uses thereof
10/19/2011EP1735332B1 Azacyclosteroid histamine-3 receptor ligands
10/19/2011EP1694334B1 Tetrahydrobenzazepines and their use in the modulation of the dopamine d3 receptor
10/19/2011EP1687024B1 Carbohydrate antigen-nanoparticle conjugates and uses thereof as antimetastatic agents in treating cancer
10/19/2011EP1640371B1 Flavanone compound and uses thereof
10/19/2011EP1622597B1 Modulation of apolipoprotein c-iii expression
10/19/2011EP1613598B1 Methods of preparing aripiprazole crystalline forms
10/19/2011EP1499613B1 Thioxanthine derivatives as myeloperoxidase inhibitors
10/19/2011EP1499321B1 Methods for increasing the therapeutic response to electroconvulsive therapy ("ect")
10/19/2011EP1494671B1 1-(4-piperidinyl)benzimidazolones as histamine h3 antagonists
10/19/2011EP1482931B1 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
10/19/2011EP1341524B1 Pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredient
10/19/2011EP1282615B1 Chroman derivatives as estrogenic compounds
10/19/2011EP1233966B2 Hydromorphinone and hydrocodeinone compositions and methods for their synthesis
10/19/2011EP1173197B2 Metabolic intervention with glp-1 to improve the function of ischemic and reperfused tissue
10/19/2011EP1139974B1 Soy depigmenting and skin care compositions
10/19/2011EP1041982B1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS
10/19/2011EP0910253B2 Peri-operative drink
10/19/2011DE202011004860U1 Arznei- oder Nahrungsergänzungsmittel zur Behandlung und/oder Prophylaxe von als negativ empfundener Geruchsbelästigung von Stoffwechselprodukten über Mund- und/oder Nasenhöhle und/oder Urin und/oder Stuhl Drugs, or dietary supplements for the treatment and / or prophylaxis of perceived negative odor of metabolites through oral and / or nasal cavity and / or urine and / or stool
10/19/2011CN202010289U Combined capsule containing hydrochlorothiazide solid formulation and aliskiren solid formulation
10/19/2011CN1993357B Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (mri) which contain a chelating moiety with polyhydroxylated substituents
10/19/2011CN1980671B Liposome preparation containing slightly water-soluble camptothecin
10/19/2011CN1964627B Methods and compositions for treating neuropathies
10/19/2011CN1874692B Lipid system and method of use
10/19/2011CN1706385B New composition for treating seasonal and perennial allergic rhinitis
10/19/2011CN1496404B Materials and methods relating to protein aggregation in neurodegenerative disease
10/19/2011CN1251097B Phthalazines with angiogenesis inhibiting activity
10/19/2011CN102224252A Novel compound signamycin, method for production thereof, and use thereof
10/19/2011CN102224242A Novel gene cluster
10/19/2011CN102224159A Bicyclic peptidomimetic inhibitors of aspartyl-proteases for the treatment of infectious diseases
10/19/2011CN102224156A Protease inhibitors
10/19/2011CN102224155A Protease inhibitors
10/19/2011CN102224154A Beta-carboline sulphonylurea derivatives as ep4 receptor antagonists
10/19/2011CN102224153A Substituted imidazo[1,2b]pyridazine compounds as trk kinase inhibitors
10/19/2011CN102224152A Pyrazolopyridine pi3k inhibitor compounds and methods of use
10/19/2011CN102224144A Sulfone-substituted anilinopyrimidine derivatives as cdk inhibitors, the production thereof, and use as a medicine
10/19/2011CN102224143A 1h-benz imidazole-5-carboxamides as anti-inflammatory agents
10/19/2011CN102224142A Novel pyrazole-3-carboxamide derivative having 5-ht2b receptor antagonist activity
10/19/2011CN102224141A Solid forms of n-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide
10/19/2011CN102224139A Novel 4-(azacycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmetics
10/19/2011CN102224138A Indole derivatives, method for preparing same and pharmaceutical compositions containing same
10/19/2011CN102224136A 3-phenyl-3-methoxypyrrolidine derivatives as modulators of cortical catecholaminergic neurotransmission
10/19/2011CN102224135A Novel 3-phenyl-azetidine derivatives useful as modulators of cortical catecholaminergic neurotransmission
10/19/2011CN102223915A New therapy and medicament using integrin ligands for treating cancer
10/19/2011CN102223897A Anti-angiogenesis therapy for the treatment of breast cancer
10/19/2011CN102223896A Anti-beta-2-microglobulin agents and the use thereof
10/19/2011CN102223886A Erbb-3 (her3)-selective combination therapy
10/19/2011CN102223885A Cdk inhibitor for the treatment of mesothelioma
10/19/2011CN102223884A Solid pharmaceutical composition
10/19/2011CN102223883A Choline salts of succinic acid for the treatment of depression, anxiety, schizophrenia, sleep disorder, and epilepsy
10/19/2011CN102223882A Phosphodiesterase type iii (pde iii) inhibitors or ca2+-sensitizing agents for the treatment of hypertrophic cardiomyopathy
10/19/2011CN102223880A Orally rapidly disintegrating tablet, and process for producing same
10/19/2011CN102223878A Liposomal systems comprising sphingomyelin
10/19/2011CN102223875A Pharmaceutical composition of a potent hcv inhibitor for oral administration
10/19/2011CN102223797A Adamantyl benzamide compounds
10/19/2011CN102223791A Topical formulations for treatment of neuropathy
10/19/2011CN102220423A Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
10/19/2011CN102219826A Polymorphs of sarsapogenin
10/19/2011CN102219822A Ganoderic acid T amide derivative TLTO-A and synthetic method and application thereof
10/19/2011CN102219821A Cardiac glycoside compounds and antitumor application thereof
10/19/2011CN102219815A Six tiacumicins compounds, preparation method and use of six tiacumicins compounds in preparing antibacterial drugs
10/19/2011CN102219812A Tumor targeting deoxyglucose composite drug and preparation method thereof
10/19/2011CN102219811A CA-4 derivatives and preparation method and medicinal application thereof
10/19/2011CN102219784A Heteroaryl urea derivatives useful for inhibiting CHKl
10/19/2011CN102219783A Vilazodone hydrochloride and composition thereof